{"schema_version":"secwatch.filing_event.v1","accession":"0001217234-25-000062","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.974181+00:00","generated_at":"2026-05-17T00:33:22.066693+00:00","sec_items":["2.02","9.01","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareDx Q3 revenue $100.1M (+21% YoY), turns to GAAP net income $1.7M; raises FY guidance","bullets":["Revenue $100.1M, up 21% YoY; testing services volume ~50,300 (+13% YoY).","GAAP net income $1.7M vs loss $10.6M in Q3 2024; adjusted EBITDA $15.3M vs $6.9M.","Raised FY 2025 revenue guidance to $372M-$376M (from $367M-$373M); raised adj. EBITDA guidance to $35M-$39M.","Cash $194.2M, no debt; repurchased $25.6M shares during quarter.","Appointed new CMO Jeff Teuteberg, MD and board member Suresh Gunasekaran."],"urls":{"canonical":"https://secwatch.observer/filing/0001217234-25-000062","json":"https://secwatch.observer/filing/0001217234-25-000062.json","markdown":"https://secwatch.observer/filing/0001217234-25-000062.md","text":"https://secwatch.observer/filing/0001217234-25-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000062/0001217234-25-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000062/cdna-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:33:22.066693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}